Mark Isbell PhD
During his time at CHR, Mark has worked in a wide range of therapeutic areas including cardiology, oncology, respiratory, infectious diseases & metabolic disorders. He is an established Project Manager within the firm covering both long-term CI monitoring engagements and deep dives including technical market landscaping, competitor threat analyses, and market defence & clinical development strategies across all major global pharmaceutical markets. He has extensive experience in mature product lifecycle management and leads CHR’s in-house expertise in EU-based regulatory, pricing, and LCM queries.
Mark holds a PhD in Chemical Engineering from Imperial College London where he studied novel solid dosage formulations in collaboration with AbbVie. He also holds a BA in Chemistry from Middlebury College in VT, USA, and was a visiting researcher at Tsinghua University’s Chemistry department in Beijing, China. Beyond consulting, Mark is an avid footballer, supporting AJ Auxerre, and is also a tennis player.